199 related articles for article (PubMed ID: 22040530)
1. Does ampicillin-sulbactam cause false positivity of (1,3)-beta-D-glucan assay? A prospective evaluation of 15 patients without invasive fungal infections.
Metan G; Agkus C; Nedret Koc A; Elmali F; Finkelman MA
Mycoses; 2012 Jul; 55(4):366-71. PubMed ID: 22040530
[TBL] [Abstract][Full Text] [Related]
2. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.
Metan G; Ağkuş C; Buldu H; Koç AN
Infection; 2010 Jun; 38(3):217-21. PubMed ID: 20237947
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
[TBL] [Abstract][Full Text] [Related]
4. Can bacteraemia lead to false positive results in 1,3-beta-D-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections.
Metan G; Koc AN; Ağkuş Ç; Kaynar LG; Alp E; Eser B
Rev Iberoam Micol; 2012; 29(3):169-71. PubMed ID: 21907303
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of DNA, (1-3)-beta-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus.
Ahmad S; Khan ZU; Theyyathel AM
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):165-71. PubMed ID: 17574786
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
[TBL] [Abstract][Full Text] [Related]
7. Detection of high serum levels of β-D-Glucan in disseminated nocardial infection: a case report.
Sawai T; Nakao T; Yamaguchi S; Yoshioka S; Matsuo N; Suyama N; Yanagihara K; Mukae H
BMC Infect Dis; 2017 Apr; 17(1):272. PubMed ID: 28407752
[TBL] [Abstract][Full Text] [Related]
8. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
[TBL] [Abstract][Full Text] [Related]
9. Introducing 1,3-beta-d-glucan for screening and diagnosis of invasive fungal diseases in Australian high-risk haematology patients: is there a clinical benefit?
Garnham K; Halliday CL; Rai NJ; Jayawardena M; Hasan T; Kok J; Nayyar V; Gottlieb DJ; Gilroy NM; Chen SC
Intern Med J; 2022 Mar; 52(3):426-435. PubMed ID: 32896984
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of serum human Galactomannan aspergillus antigen and 1,3-beta-D-glucan in immunocompromised patient suspected fungal infection.
Susianti H; Parmadi L; Firani NK; Setyawan UA; Sartono TR
J Clin Lab Anal; 2021 Jun; 35(6):e23806. PubMed ID: 33945177
[TBL] [Abstract][Full Text] [Related]
11. Serum (1→3)-β-D-glucan and galactomannan levels in patients with cystic fibrosis: a retrospective cohort study.
Träger J; Melichar VO; Meyer R; Rauh M; Bogdan C; Held J
BMC Pulm Med; 2018 Mar; 18(1):52. PubMed ID: 29587700
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
White PL; Price JS; Posso RB; Barnes RA
Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
[TBL] [Abstract][Full Text] [Related]
13. Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.
Sulahian A; Porcher R; Bergeron A; Touratier S; Raffoux E; Menotti J; Derouin F; Ribaud P
J Clin Microbiol; 2014 Jul; 52(7):2328-33. PubMed ID: 24740084
[TBL] [Abstract][Full Text] [Related]
14. False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients.
Fortún J; Martín-Dávila P; Alvarez ME; Norman F; Sánchez-Sousa A; Gajate L; Bárcena R; Nuño SJ; Moreno S
Transplantation; 2009 Jan; 87(2):256-60. PubMed ID: 19155981
[TBL] [Abstract][Full Text] [Related]
15. β-1,3-d-Glucan and Galactomannan as Biomarkers for the Detection of Invasive
Forster J; Koc Ö; Koeppel MB; Hamprecht A; Kurzai O; Suerbaum S; Wagener J; Dichtl K
J Clin Microbiol; 2022 Jan; 60(1):e0160721. PubMed ID: 34669454
[No Abstract] [Full Text] [Related]
16. Reliability of serum 1,3-beta-D-glucan assay in patients undergoing renal replacement therapy: a review of the literature.
Prattes J; Schilcher G; Krause R
Mycoses; 2015 Jan; 58(1):4-9. PubMed ID: 25339221
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.
Alam FF; Mustafa AS; Khan ZU
BMC Infect Dis; 2007 Sep; 7():103. PubMed ID: 17784947
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
Pini P; Bettua C; Orsi CF; Venturelli C; Forghieri F; Bigliardi S; Faglioni L; Luppi F; Serio L; Codeluppi M; Luppi M; Mussini C; Girardis M; Blasi E
Infection; 2016 Apr; 44(2):223-33. PubMed ID: 26475482
[TBL] [Abstract][Full Text] [Related]
19. Comparative Analysis of the Wako β-Glucan Test and the Fungitell Assay for Diagnosis of Candidemia and Pneumocystis jirovecii Pneumonia.
Friedrich R; Rappold E; Bogdan C; Held J
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29899003
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.
Gupta P; Ahmad A; Khare V; Kumar A; Banerjee G; Verma N; Singh M
Mycoses; 2017 Apr; 60(4):234-240. PubMed ID: 27862370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
